Aleve Easy Open Arthritis Capnaproxen

According to the FDA label: Naproxen tablets and naproxen sodium tablets are indicated for: the relief of the signs and symptoms of: • rheumatoid arthritis • osteoarthritis • ankylosing spondylitis • Polyarticular Juvenile Idiopathic Arthritis Naproxen tablets and naproxen sodium tablets are also indicated for: the relief of signs and symptoms of: • tendonitis • bursitis • acute gout the management of: • pain • primary dysmenorrhea Naproxen tablets and naproxen sodium tablets are non-steroidal anti-inflammatory drugs…

65,469 adverse event reports submitted to the FDA (2002–2026)

This data reflects voluntary reports submitted to the FDA's Adverse Event Monitoring System (AEMS), formerly the FDA Adverse Event Reporting System (FAERS). A report does not mean the medication caused the event. Data may be incomplete or contain errors. Learn more about AEMS. New to this data? Read our guide on how to interpret FDA adverse event reports →
New to FDA adverse event data? Here's how to read these reports →

Top Reported Adverse Events

The most frequently reported events in association with Aleve Easy Open Arthritis Cap in the FAERS database. These are events reported by patients taking this medication, not necessarily caused by it. A single report may include multiple events.

Show these terms with plain-language definitions

Tap any term below for a plain-language definition.

Browse the full glossary →

Ranked by frequency of reports, not severity. The most-reported event is not necessarily the most dangerous or the most common in patients taking this drug.

Who Is Reporting

Demographics of patients in FAERS reports that included this information. Not all reports include patient demographics.

By Sex

View reporter sex data as a table
Aleve Easy Open Arthritis Cap adverse event reports by reporter sex
SexReports
Female38,987
Male16,936
Unknown81

By Age Group

View age group data as a table
Aleve Easy Open Arthritis Cap adverse event reports by reporter age group
Age groupReports
0-171,097
18-342,909
35-497,574
50-6410,252
65-747,159
75+7,408

This shows who filed reports, reflecting who takes this drug and who tends to report, not who is at greatest risk.

Reported Outcomes

Outcomes recorded in FAERS reports that included Aleve Easy Open Arthritis Cap. A single report may involve multiple reactions, each with a different outcome. These categories are defined by FDA reporting guidelines, not by PillSignal.

View outcome data as a table
Aleve Easy Open Arthritis Cap adverse event reports by reported outcome
OutcomeReports
Non-Serious38,770
Other Serious19,828
Hospitalization11,840
Death4,673
Disability4,383
Life-Threatening4,378

Serious outcomes are far more likely to be reported than mild ones, so this overstates how often outcomes are serious. A recorded death does not mean the drug caused it.

Number of FAERS reports received per quarter for Aleve Easy Open Arthritis Cap. Changes in volume may reflect shifts in prescribing rates, media attention, or reporting behavior, not changes in the medication's safety profile.

View report trend as a table
Aleve Easy Open Arthritis Cap adverse event reports by year
YearReports
20021
20031
2004644
2005773
2006632
2007658
20083,280
20091,851
2010786
20111,013
20121,807
20131,555
20143,689
20157,073
20166,845
20175,778
20184,836
20194,630
20203,585
20213,019
20222,928
20232,817
20243,525
20253,237
2026 (partial)506

The steep increase around 2004 reflects the FDA's move to electronic submission, not a change in this drug's safety. Trends track reporting volume, not risk.

Medications commonly reported with Aleve Easy Open Arthritis Cap

In FDA adverse event reports that mention Aleve Easy Open Arthritis Cap, these medications appeared most often in the same report.

This reflects co-occurrence in submitted reports, not evidence of drug interaction or combined risk. People often report several medications taken for the same condition or for unrelated reasons. Talk to a doctor or pharmacist about your specific medications.

Other medications with similar adverse event profiles in FDA FAERS reports.

Data Source

This data is sourced from the FDA's Adverse Event Monitoring System (AEMS), formerly FAERS, via the OpenFDA API. PillSignal is not affiliated with the FDA.

View this data on the FDA website →

Data last updated: June 2026